Quadrant Capital Group LLC Ultragenyx Pharmaceutical Inc. Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 287 shares of RARE stock, worth $13,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares

287

Previous 287 -0.0%

Holding current value

$13,672

Previous $11,000 36.36%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$37.42 - $51.61 $4,116 - $5,677	-110 Reduced 27.71%	287 $11,000
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $3,441 - $4,295	80 Added 25.24%	397 $18,000
Q4 2023 Feb 08, 2024	SELL	$31.73 - $49.19 $2,982 - $4,623	-94 Reduced 22.87%	317 $15,000
Q3 2023 Nov 14, 2023	SELL	$34.92 - $46.66 $26,399 - $35,274	-756 Reduced 64.78%	411 $14,000
Q2 2023 Aug 09, 2023	SELL	$37.35 - $52.15 $6,088 - $8,500	-163 Reduced 12.26%	1,167 $53,000
Q1 2023 May 11, 2023	BUY	$36.99 - $48.71 $15,017 - $19,776	406 Added 43.94%	1,330 $53,000
Q4 2022 Feb 10, 2023	BUY	$33.72 - $46.33 $16,421 - $22,562	487 Added 111.44%	924 $42,000
Q3 2022 Nov 10, 2022	BUY	$39.96 - $66.14 $10,629 - $17,593	266 Added 155.56%	437 $18,000
Q2 2022 Aug 09, 2022	BUY	$45.8 - $85.4 $6,824 - $12,724	149 Added 677.27%	171 $10,000
Q1 2022 May 06, 2022	SELL	$62.2 - $84.4 $2,301 - $3,122	-37 Reduced 62.71%	22 $1,000
Q4 2021 Feb 01, 2022	BUY	$73.71 - $87.86 $2,506 - $2,987	34 Added 136.0%	59 $5,000
Q3 2021 Nov 12, 2021	BUY	$77.92 - $102.4 $1,714 - $2,252	22 Added 733.33%	25 $2,000
Q2 2021 Aug 09, 2021	SELL	$92.19 - $115.71 $4,978 - $6,248	-54 Reduced 94.74%	3 $0
Q1 2021 May 12, 2021	BUY	$106.9 - $167.73 $6,093 - $9,560	57 New	57 $6,000
Q2 2020 Aug 13, 2020	SELL	$46.91 - $78.22 $187 - $312	-4 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$33.8 - $62.9 $135 - $251	4 New	4 $0
Q4 2019 Feb 03, 2020	SELL	$36.08 - $45.83 $4,906 - $6,232	-136 Closed	0 $0
Q3 2019 Oct 24, 2019	BUY	$42.5 - $63.11 $5,780 - $8,582	136 New	136 $5,000

Others Institutions Holding RARE

# of Institutions

322

Shares Held

85.5M

Call Options Held

668K

Put Options Held

288K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.34B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Ultragenyx Pharmaceutical Inc. Transaction History